GLP1R and type 2 diabetes mellitus: These initial experiments convinced us that this cell line was a suitable model for understanding how alpha cells react to prolonged exposure to high GLP-1 levels (as experienced by type 2 diabetes patients treated with DPP-IV inhibitors or GLP-1 analogues).